Sight Diagnostics raised $28 million from the issuance of private preferred stock.
Read more on Israel21c here.
Sight Diagnostics raised $28 million from the issuance of private preferred stock.
Read more on Israel21c here.
![[BioCatch in Bankless Times] BioCatch and the process of continuous authentication](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
